These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2256173)

  • 1. The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
    Bittar AE; Ratcliffe PJ; Richardson AJ; Raine AE; Jones L; Yudkin PL; Carter R; Mann JI; Morris PJ
    Transplantation; 1990 Dec; 50(6):987-92. PubMed ID: 2256173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the development and progression of dyslipidemia after heart transplantation.
    Akhlaghi F; Jackson CH; Parameshwar J; Sharples LD; Trull AK
    Transplantation; 2002 Apr; 73(8):1258-64. PubMed ID: 11981418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression enhances atherogenicity of lipid profile after transplantation.
    Quaschning T; Mainka T; Nauck M; Rump LC; Wanner C; Krämer-Guth A
    Kidney Int Suppl; 1999 Jul; 71():S235-7. PubMed ID: 10412786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia in stable renal transplant recipients.
    Divakar D; Bailey RR; Frampton CM; George PM; Walmsley TA; Murphy J
    Nephron; 1991; 59(3):423-8. PubMed ID: 1758532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and transplantation: etiologic factors and therapy.
    Pirsch JD; D'Alessandro AM; Sollinger HW; Knechtle SJ; Reed A; Kalayoglu M; Belzer FO
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S238-42. PubMed ID: 1498281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidaemia in renal transplant patients.
    Aakhus S; Dahl K; Widerøe TE
    J Intern Med; 1996 May; 239(5):407-15. PubMed ID: 8642233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
    Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent hyperlipidemia in renal transplant patients.
    Kasiske BL; Umen AJ
    Medicine (Baltimore); 1987 Jul; 66(4):309-16. PubMed ID: 3298932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
    Swenson JM; Fricker FJ; Armitage JM
    J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.
    Becker DM; Chamberlain B; Swank R; Hegewald MG; Girardet R; Baughman KL; Kwiterovich PO; Pearson TA; Ettinger WH; Renlund D
    Am J Med; 1988 Nov; 85(5):632-8. PubMed ID: 3055976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of cyclosporine blood levels to adverse effects on lipoproteins.
    Kuster GM; Drexel H; Bleisch JA; Rentsch K; Pei P; Binswanger U; Amann FW
    Transplantation; 1994 May; 57(10):1479-83. PubMed ID: 8197611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
    Föger B; Königsrainer A; Palos G; Brandstätter E; Ritsch A; König P; Miesenböck G; Lechleitner M; Margreiter R; Patsch JR
    Transplantation; 1994 Oct; 58(8):899-904. PubMed ID: 7940733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia.
    Hricik DE; Mayes JT; Schulak JA
    Am J Kidney Dis; 1991 Sep; 18(3):353-8. PubMed ID: 1882828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.